Back to Search
Start Over
Phase II clinical trials update: April 2008
- Source :
- Bioworld Financial Watch. May 12, 2008, Vol. 16 Issue 19, p10, 6 p.
- Publication Year :
- 2008
-
Abstract
- Phase II Clinical Trials Update: April 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Genentech Inc. Rituxan Rituximab (NYSE:DNA) and (FDA-approved) Biogen Idec Inc. (BIIB) ZymoGenetics Inc. Atacicept Antagonist protein [...]
- Subjects :
- ChemGenics Pharmaceuticals Inc. -- Product development
Genentech Inc. -- Product development
ZymoGenetics Inc. -- Product development
Biological products industry -- Product development
Biotechnology industry -- Product development
Pharmaceutical industry -- Product development
Banking, finance and accounting industries
Biotechnology industry
Atacicept (Medication) -- Product development
Ceflatonin (Medication) -- Product development
Rituxan (Medication) -- Product development
Subjects
Details
- Language :
- English
- ISSN :
- 15410579
- Volume :
- 16
- Issue :
- 19
- Database :
- Gale General OneFile
- Journal :
- Bioworld Financial Watch
- Publication Type :
- News
- Accession number :
- edsgcl.179329008